Closed |
S0307A |
ANCILLARY: S0307 Companion Study |
10/1/2008 |
2/1/2010 |
0% |
|
|
Closed |
S0308 |
Reduction of Skeletal Events in Advanced Breast Cancer |
5/15/2006 |
6/8/2006 |
0% |
|
|
Closed |
S0309 |
Myeloma Repository |
11/15/2003 |
|
|
|
|
Closed |
S0310 |
CG8123 (GVAX) in selected Stage IIIB and IV BAC |
3/1/2004 |
8/19/2005 |
16% |
|
|
Closed |
S0312 |
Advanced Renal |
12/1/2004 |
8/15/2005 |
100% |
|
Published
|
Closed |
S0313 |
NON-HODGKIN'S: CHOP + IF RT followed by Yttrium-90 Ibritumomab Tiuxetan |
2/1/2004 |
12/15/2008 |
77% |
|
Published
|
Closed |
S0316 |
Barriers to Accrual |
8/1/2004 |
6/15/2008 |
97% |
|
Published
|
Closed |
S0317 |
Advanced Renal |
5/1/2003 |
12/15/2005 |
100% |
|
Published
|
Closed |
S0322 |
ZD1839/75 yrs or older and in a cohort of 50 yrs or older/Adv. H&N NSCLC |
8/15/2003 |
2/15/2005 |
25% |
|
|
Closed |
S0325 |
Phase IIb Imatinib or Dasatinib for Untreated Chronic CML |
8/15/2004 |
2/28/2009 |
100% |
|
Published
|
Closed |
S0327 |
PS-341/Platinum-treated/Extensive SCLC |
9/1/2003 |
9/15/2004 |
75% |
|
Published
|
Closed |
S0329 |
Recurrent of Metastatic Squamous Cell Carcinoma of the Head and Neck |
1/1/2005 |
1/1/2007 |
100% |
|
Published
|
Closed |
S0330 |
Malignant Peripheral Nerve Sheath Tumors |
12/15/2003 |
1/15/2006 |
60% |
|
Published
|
Closed |
S0331 |
STI-571/Imatinib/Merkel Cell Melanoma |
10/1/2003 |
3/1/2007 |
62% |
|
Published
|
Closed |
S0333 |
Phase II Double Induction for Newly Diagnosed Non-L3 ALL |
4/15/2005 |
|
100% |
|
|
Closed |
S0334 |
Cytogenetics and FISH in Multiple Myeloma |
9/1/2005 |
6/15/2007 |
|
|
|
Closed |
S0336 |
COLORECTAL |
4/15/2004 |
9/1/2005 |
70% |
|
Published
|
Closed |
S0337 |
Superficial Bladder, Post-TURBT Gemcitabine vs Saline, Ph III |
7/15/2007 |
8/15/2012 |
100% |
|
|
Closed |
S0338 |
ADVANCED: Imatinib Mesylate Plus Capecitabine for Stage IV Breast Cancer |
6/15/2004 |
12/15/2005 |
39% |
|
Published
|
Closed |
S0339 |
Gemcitabine/Carboplatin & PS-341/NSCLC |
1/15/2004 |
10/1/2004 |
100% |
|
Published
|